FDA Inspection 1087869 — Octapharma Plasma Inc.

Octapharma Plasma Inc. — FEI 3007721571

The FDA completed an inspection of Octapharma Plasma Inc. on April 16, 2019 in Maple Heights, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 16, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Maple Heights, OH (United States)